This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seeherman, H.
Right arrow Articles by Wozney, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seeherman, H.
Right arrow Articles by Wozney, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?
The Journal of Bone and Joint Surgery (American) 85:96-108 (2003)
© 2003 The Journal of Bone and Joint Surgery, Inc.

Orthopaedic Applications

A Review of Preclinical Program Development for Evaluating Injectable Carriers for Osteogenic Factors

Howard Seeherman, PhD, VMD, Rebecca Li, PhD and John Wozney, PhD

Corresponding author: Howard Seeherman, PhD, VMDWyeth Research, 87 Cambridge Park Drive, Cambridge, MA 02140. E-mail address: hseeherman@wyeth.com

The research for this paper was sponsored by Wyeth. All three authors are employees of Wyeth. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, educational institution, or other charitable or nonprofit organization with which the authors are affiliated or associated.

The first 150 words of the full text of this article appear below.

Recombinant human bone morphogenetic protein-2 (rhBMP-2) delivered with an absorbable collagen sponge (ACS) has been used to both accelerate and ensure healing of open tibial fractures in human patients 1,2 . Recombinant human osteogenic protein-1 (rhOP-1, rhBMP-7) delivered with type-1 bovine bone-derived collagen has also been used to treat tibial nonunions in patients 3 . A major limitation of both of these biomaterials is the requirement for open surgical placement, which prevents treatment of patients with a closed fracture managed by closed reduction. This represents a substantial patient population, since closed fractures constitute the vast majority of the 6.3 million fractures seen annually in the United States 4 . Development of an injectable carrier for osteogenic factors would allow treatment of closed fractures and would also overcome several other limitations of current implantable carriers. Placement of implantable products during the repair of open long-bone fractures is generally limited to areas of exposed bone . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Journal of the American Dental AssociationHome page
P. G. Robey and P. Bianco
The use of adult stem cells in rebuilding the human face.
J Am Dent Assoc, July 1, 2006; 137(7): 961 - 972.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
H. Seeherman, R. Li, M. Bouxsein, H. Kim, X. J. Li, E. A. Smith-Adaline, M. Aiolova, and J. M. Wozney
rhBMP-2/Calcium Phosphate Matrix Accelerates Osteotomy-Site Healing in a Nonhuman Primate Model at Multiple Treatment Times and Concentrations
J. Bone Joint Surg. Am., January 1, 2006; 88(1): 144 - 160.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
H. J. Seeherman, M. Bouxsein, H. Kim, R. Li, X. J. Li, M. Aiolova, and J. M. Wozney
Recombinant Human Bone Morphogenetic Protein-2 Delivered in an Injectable Calcium Phosphate Paste Accelerates Osteotomy-Site Healing in a Nonhuman Primate Model
J. Bone Joint Surg. Am., September 1, 2004; 86(9): 1961 - 1972.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
L. C. Rosenberg
Introductory Comments
J. Bone Joint Surg. Am., August 1, 2003; 85(90003): 1 - 2.
[Full Text] [PDF]

Home page
 JBJSHome page
T. A. Einhorn
Clinical Applications of Recombinant Human BMPs: Early Experience and Future Development
J. Bone Joint Surg. Am., August 1, 2003; 85(90003): 82 - 88.
[Full Text] [PDF]